通过新型药理学药物推进COPD治疗:恩西芬和杜比卢马布
Lauren L Walkon1, James R Burmeister1, Michael Nazmifar1
1Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
两种新疗法,恩西芬林和杜皮卢马布,为COPD提供精确药物,改善肺功能并减少特定患者群体的恶化. 这些治疗针对潜在的炎症,以更好地管理慢性阻塞性肺病.
科学领域:
- 肺病学和呼吸系统医学
- 药理学和治疗学 药理学和治疗学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性呼吸道疾病,具有持续的空气流量限制和炎症.
- 目前的治疗方法,如支气管扩展剂和皮质类固醇,对于许多患者来说是不够的,特别是那些患有酸性炎症的患者.
- 存在针对特定COPD内型的向治疗的需要.
研究的目的:
- 审查两种新疗法,恩西芬林和杜比卢马布,用于COPD管理.
- 突出其作用机制和临床试验证据.
- 为了强调在COPD中向精准医学的转变.
主要方法:
- 对最近的临床试验 (ENHANCE,BOREAS,NOTUS) 对恩西芬和杜比卢马布的综述.
- 治疗标的分析:双二酶3和4抑制 (恩西芬林) 和介素-4/13信号阻断 (dupilumab).
- 对改善肺功能和减少恶化的疗效的评估.
主要成果:
- 恩西芬显示出支气管扩张和抗炎作用,改善肺功能和减少恶化.
- 杜皮卢马布向乙型COPD的2型炎症,显示出显著的临床益处.
- 这两种疗法都在1秒内改善了强迫呼气体积 (FEV1) 和选择的患者子组的生活质量.
结论:
- 恩西芬和杜皮卢马布代表了对COPD精准医学的范式转变.
- 这些疗法在基于疾病内型的特定患者群体中是有效的.
- 对生物标志物和长期结果的进一步研究对于临床整合至关重要.
更多相关视频
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
04:44Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
